Design Therapeutics

0 followers


Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.


Employees

51-200

Links

Org chart

Aaron Young
Head of HR and People
James Gomez
Senior Contract Manager
Jim Kerr
Sr Vice President Of Product Development
Julie Burgess
Chief Accounting Officer
Laura Weston
Vice President Of Product Development
Mustapha Parekh
General Counsel
Nancy Levin
Vice President